Complete the form to view this complimentary recording from the AI in Drug Development Virtual Roundtable on July 26, 2022 and explore the opportunities and challenges associated with adopting AI and ML in translational research and drug discovery.
- Peter Henstock, Machine Learning & AI Technical Lead: Combine AI, Software Engineering Statistics & Visualization, Pfizer
- Christos Varsakelis, Associate Director AI/ML, In Silico Drug Discovery & External Innovation, The Janssen Pharmaceutical Companies of Johnson & Johnson
- Andrea Derix, R&D Global Program Management, Bayer Pharmaceuticals
- Szczepan Baran, MS, VMD, Chief Scientific Officer, VeriSIM Life